Lilly beats 2nd qtr forecasts, raises '07 view
16405
Eli Lilly and Co.  on Tuesday posted better-than-expected second-quarter earnings helped by surging sales of its prescription drugs, including depression treatment Cymbalta, and the company raised its 2007 profit forecast.
101921
Eli Lilly & Company reported fourth-quarter earnings of $854.4 million, or 78 cents a share, compared with $132.3 million, or 12 cents a share, a year ago.
331407
The company reported strong second-quarter results and said its profits for all of 2007 would beat analystsâ expectations.
314491
The company said it earned $52 million in the fourth quarter on strong U.S. and international sales. Its shares climbed more than 7 percent in morning trading.
349930
Heavy equipment maker Caterpillar Inc.   posted better-than-expected quarterly earnings on  Friday and raised its outlook for the full year, bolstered by  strong sales to the mining industry.
527030
Drugmaker Merck & Co. Inc.   boosted its 2007 earnings forecast on Wednesday, citing  higher-than-expected sales of multiple products, including its  cancer vaccine Gardasil and diabetes drug Januvia.
628463
Eli Lilly and Co.  forecast profit gains next year below its expected 2006 growth of 8 percent to 12 percent, held back by higher costs.
338323
Johnson & Johnson  on Tuesday said second-quarter profit rose on higher sales of medical devices and prescription drugs, beating Wall Street expectations on especially strong demand in overseas markets.
733339
Eli Lilly and Co.  on Tuesday posted better-than-expected quarterly earnings and raised its 2007 forecast, helped by surging sales of its prescription drugs, including depression treatment Cymbalta.
67048
Eli Lilly and Co  on Tuesday said fourth-quarter profit rose on lower taxes and better-than-expected sales of its medicines, including newer treatments for depression, diabetes and cancer.
2963
U.S. drug benefit manager Medco Health Solutions Inc.  on Wednesday reported a higher-than-expected quarterly profit on strong demand for mail-delivered generic medicines and raised its 2007 outlook, sending its shares up more than 11 percent to an all-time high.
377994
Drugmaker Merck & Co. Inc.  boosted its 2007 earnings forecast on Wednesday, citing better-than-expected sales of multiple products, including its cancer vaccine Gardasil and diabetes drug Januvia.
402815
NEW YORK -- Pharmaceutical company Eli Lilly and Co. on Thursday issued 2007 earnings estimates that are below Wall Street's current expectations.
573112
Eli Lilly and Co.  on Thursday said its third-quarter earnings rose as growing demand for its medicines offset higher spending to market recently approved treatments.
120971
U.S. stocks were little changed on   Friday as declines in shares of Eli Lilly and Co. LLY.N   offset a report on personal income and consumption that raised   no new worries about interest rates going higher.
675913
Eli Lilly and Co. said its strategy of staying independent and plowing money into research should pay off in 2005, with profits expected to jump 8 percent to 12 percent over 2004 and nine new drugs in advanced human testing.
724714
CVS Corp. , the No. 2 U.S.  drugstore chain, posted a 2.7 percent rise in quarterly profit  on Thursday, driven by strong sales of prescription medications  and greater use of generic drugs, which are more profitable for  pharmacies.